Literature DB >> 19438732

The evolution of chronic migraine: classification and nomenclature.

Aubrey Manack1, Catherine Turkel, Stephen Silberstein.   

Abstract

After nearly 3 decades of debate, the headache community still lacks globally accepted criteria for chronic migraine. This review summarizes the evolution of chronic migraine nomenclature and criteria. We concluded that although there are discrepancies in the currently proposed criteria, there is a significant amount of overlap with previously used classifications such that they all appear to describe the same subset of highly burdened migraine patients. In order to continue to understand the natural history of chronic migraine, address the unmet medical need, and develop effective therapies, field experts and physicians must have a classification that is well understood and accepted by the broader clinical community. It is our view that of the currently established classifications, the Silberstein and Lipton revised criteria for transformed migraine are the most applicable to daily clinical practice and field research.

Entities:  

Mesh:

Year:  2009        PMID: 19438732     DOI: 10.1111/j.1526-4610.2009.01432.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

Review 1.  ICHD-3: what changes do we need regarding migraine?

Authors:  Gian Camillo Manzoni; Ilaria Grisendi; Paola Torelli
Journal:  Curr Pain Headache Rep       Date:  2011-06

2.  Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.

Authors:  Giovanna Gentile; Serena Missori; Marina Borro; Alisa Sebastianelli; Maurizio Simmaco; Paolo Martelletti
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

Review 3.  Sleep in Patients with Chronic Migraine.

Authors:  Chun-Pai Yang; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2017-09

Review 4.  Chronic daily headache in children and adolescents.

Authors:  Shashi S Seshia
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 5.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 6.  Chronic migraine: epidemiology and disease burden.

Authors:  Aubrey N Manack; Dawn C Buse; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 7.  Psychiatric comorbidities of episodic and chronic migraine.

Authors:  Dawn C Buse; Stephen D Silberstein; Aubrey N Manack; Spyros Papapetropoulos; Richard B Lipton
Journal:  J Neurol       Date:  2012-11-07       Impact factor: 4.849

Review 8.  Chronic migraine classification: current knowledge and future perspectives.

Authors:  Gian Camillo Manzoni; Vincenzo Bonavita; Gennaro Bussone; Pietro Cortelli; Maria Carola Narbone; Sabina Cevoli; Domenico D'Amico; Roberto De Simone; Paola Torelli
Journal:  J Headache Pain       Date:  2011-10-26       Impact factor: 7.277

Review 9.  OnabotulinumtoxinA for chronic migraine: a critical appraisal.

Authors:  Rubesh Gooriah; Fayyaz Ahmed
Journal:  Ther Clin Risk Manag       Date:  2015-06-29       Impact factor: 2.423

10.  The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results.

Authors:  Aubrey Manack Adams; Daniel Serrano; Dawn C Buse; Michael L Reed; Valerie Marske; Kristina M Fanning; Richard B Lipton
Journal:  Cephalalgia       Date:  2014-10-10       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.